Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women (NCT03916978) | Clinical Trial Compass
RecruitingPhase 2/3
Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
Greece100 participantsStarted 2019-05-21
Plain-language summary
Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.
Who can participate
Age range45 Years – 55 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 45-55 years old
* Amenorrhea for at least 12 months
* Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment.
* Willing to comply with study requirements
Exclusion Criteria:
* Any pathological disorder related to reproductive system anatomy
* Previous POI diagnosis
* Abnormal karyotype
* Endometriosis
* Adenomyosis
* Fibroids and adhesions
* Infections in reproductive system
* Current or previous diagnosis of reproductive system cancer
* History of familiar cancer in reproductive system
* Severe male factor infertility
* Prior referral for PGT
* Ovarian inaccessibility
* Endocrinological disorders (Hypothalamus-Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)
* BMI\>30 kg/m2 or BMI\<18.5 kg/m2
* Systematic autoimmune disorders
What they're measuring
1
Restoration of menstrual cycle
Timeframe: Three months
2
Serum FSH levels
Timeframe: Follow-up period of three months entailing monthly evaluation